Group One Trading
ALDR

Group One Trading’s Alder Biopharmaceuticals ALDR Stock Holding History

Group One Trading’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-230,300
Closed -$4.34M – 5977
2019
Q3 		$4.34M Buy
230,300
+227,800
+9,112% +$2.61M 0.04% 670
2019
Q2 		$29K Buy
+2,500
New +$30.3K ﹤0.01% 4039
2019
Q1 		– Sell
-4,900
Closed -$50K – 5695
2018
Q4 		$50K Sell
4,900
-1,500
-23% -$19.2K ﹤0.01% 3570
2018
Q3 		$107K Sell
6,400
-2,200
-26% -$39.8K ﹤0.01% 3491
2018
Q2 		$136K Sell
8,600
-10,600
-55% -$161K ﹤0.01% 3361
2018
Q1 		$244K Buy
19,200
+12,400
+182% +$179K ﹤0.01% 2625
2017
Q4 		$78K Sell
6,800
-70,600
-91% -$788K ﹤0.01% 3499
2017
Q3 		$948K Buy
77,400
+44,000
+132% +$459K 0.01% 1603
2017
Q2 		$382K Buy
+33,400
New +$617K ﹤0.01% 2172
2017
Q1 		– Sell
-2,500
Closed -$52K – 5222
2016
Q4 		$52K Buy
+2,500
New +$65K ﹤0.01% 3249

Group One Trading's ALDR Position: Q4 2019 in Review

Group One Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 25,332 shares — an estimated $478K sold.

Group One Trading first reported a position in ALDR in Q2 2015 and held it in 16 quarters. The position peaked at $824K in Q3 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Group One Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Group One Trading sold 25,332 Alder Biopharmaceuticals shares in Q4 2019, an estimated $478K.
  • Group One Trading first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 16 quarters.
  • Group One Trading's Alder Biopharmaceuticals position peaked at $824K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Group One Trading's 13F filing for Q4 2019, filed 10 Feb 2020.